Aquatic mobility test for infants with SMA
Official title: Analysis of Mobility in the Bath for Infants Affected With Spinal Muscular Atrophy
Run by Assistance Publique - Hôpitaux de Paris · NCT06152302 · Data updated 2026-11-12
This project will test whether a standardized bath test with wearable inertial sensors can reveal hidden motor abilities in infants with type 1 spinal muscular atrophy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 12 Months |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Garches) |
| Status | Recruiting |
| Started | June 26, 2025 |
| Main results expected | June 2026 |
| Study ends | June 2026 |
| Registry record updated | November 21, 2025 |
| Trial ID | NCT06152302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants with genetically confirmed SMA type 1 (onset before 6 months), under 12 years and shorter than 90 cm, receiving standard care, and whose parents provide informed consent are ideal candidates.
✕Probably not a fit
Infants with spinal cord lesions, significant cardiorespiratory disease, those covered by the AME program, or children who already demonstrate sufficient mobility on land may not gain additional information from this test.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter French project will compare infant mobility in standardized dry and in-water conditions using a 'bath test' protocol combined with wearable inertial sensors to detect subtle movements. Infants with genetically confirmed SMA type 1 will be recorded during routine follow-up visits at three pediatric neurology centers coordinated by Raymond Poincaré Hospital. The protocol aims to standardize recording conditions, quantify water-assisted movements, and track changes over time or after therapies. Parental consent is required and common exclusions include spinal cord lesions and significant cardiorespiratory disease.
Why it matters
Potential benefit: If successful, this could reveal previously undetected motor activity and provide a standardized way to track progression or treatment response in severely hypotonic SMA infants.
How similar studies have gone: Pediatric neurologists have used parent-provided bath videos anecdotally and there is emerging interest, but a standardized sensor-based aquatic mobility test is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants with muscle weakness (commonly referred to as floppy babies): * Confirmed diagnosis of SMA through gene mutation or deletion (SMN1 gene). * Receiving standard care. * Age less than 12 years and a height of less than 90 cm at the time of inclusion. * Patients enrolled in a social security scheme. * Informed consent signed by both parents of the child and the investigator. Exclusion Criteria: * Patients presenting with lesions in the spinal cord or conditions affecting the cardiorespiratory system. * Patients covered under the French Aid in Health for Foreign People program (AME).
Where it's running
-
Infantile neuromuscular unity - Department of paediatric neurological care and intentive care unity, Raymond Poincaré Hospital - APHP
Garches, France Recruiting
Study contacts
- Principal investigator: Susana Quijano-Roy, MD, PhD — Paediatric neurological and intentive care unity, Raymond Poincaré Hospital - APHP
- Study coordinator: Susana Quijano-Roy, MD, PhD
- Email: susana.quijano-roy@aphp.fr
- Phone: + 33 1 47 10 78 90
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing fatigue levels in patients with spinal muscular atrophy
This study is testing new ways to measure fatigue in people with spinal muscular atrophy to help them manage their daily activities better.
-
Diffusion MRI to map nerve lesions in obstetric brachial plexus palsy
This study tests diffusion MRI and tractography to better understand nerve injuries in people with obstetric brachial plexus palsy.
-
Long-term心理 and cognitive check after stem cell transplant for immune deficiencies
This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.
-
Benchmarking AI language models against tumor boards for oncology treatment decisions
This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.
-
Gut microbes and autoinflammatory diseases: how they may be linked
This study tests whether gut bacteria and their byproducts relate to digestive and inflammatory symptoms in people with autoinflammatory diseases.
-
How Eye Dominance Affects Fusion in Healthy Adults
This study tests whether fusional vergence measurements differ when tested on the dominant eye versus the non-dominant eye in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.